Medical Research News

RSS

Deadly neurodegenerative disease treated in worms gives hope for humans

An untreatable and deadly neurodegenerative disease has been modelled and treated in worms by University of Liverpool researchers, suggesting a cure could be found for humans.

17 Jul 2014

Phase III research shows that new drug improves symptoms related to plaque psoriasis

Randomized, phase III research from the University of Alabama at Birmingham shows that a new drug improves symptoms related to moderate to severe plaque psoriasis, a chronic skin disease of scaling and inflammation.

17 Jul 2014

Investigators identify gene that underlies devastating autoinflammatory condition in children

Investigators have identified a gene that underlies a very rare but devastating autoinflammatory condition in children. Several existing drugs have shown therapeutic potential in laboratory studies, and one is currently being studied in children with the disease, which the researchers named STING-associated vasculopathy with onset in infancy (SAVI).

17 Jul 2014

Scientists reveal secrets of cell membrane proteins

Rice University scientists have succeeded in analyzing transmembrane protein folding in the same way they study the proteins' free-floating, globular cousins.

17 Jul 2014

People with mild traumatic brain injury may have brain damage and memory problems

Even mild traumatic brain injury may cause brain damage and thinking and memory problems, according to a study published in the July 16, 2014, online issue of Neurology, the medical journal of the American Academy of Neurology.

17 Jul 2014

Robot-assisted surgery to control prostate cancer effective in controlling disease for 10 years

Robot-assisted surgery to remove cancerous prostate glands is effective in controlling the disease for 10 years, according to a new study led by researchers at Henry Ford Hospital.

17 Jul 2014

Scientist fights extremely aggressive and difficult-to-treat form of breast cancer

Biomedical scientist Kimberly L. Koss, PhD, is fighting an extremely aggressive and difficult-to-treat form of breast cancer.

17 Jul 2014

Potassium supplements with loop diuretics increase survival rates of heart failure patients

Researchers from the Perelman School of Medicine at the University of Pennsylvania found that patients taking prescription potassium supplements together with loop diuretics for heart failure have better survival rates than patients taking diuretics without the potassium. Moreover, the degree of benefit increases with higher diuretic doses.

17 Jul 2014

Single injection of protein FGF1 enough to restore blood sugar levels

In mice with diet-induced diabetes—the equivalent of type 2 diabetes in humans—a single injection of the protein FGF1 is enough to restore blood sugar levels to a healthy range for more than two days.

17 Jul 2014

Scientists may be able to entomb malaria parasite in prison

Scientists may be able to entomb the malaria parasite in a prison of its own making, researchers at Washington University School of Medicine in St. Louis report July 16 in Nature.

17 Jul 2014

Symptom remission main predictor of functional outcomes in psychosis

Remission of positive and negative symptoms is the most important predictor of functional outcomes among patients with first-episode psychosis, with cognition having only a small impact, say researchers.

16 Jul 2014

TAZ represents a novel therapeutic target in NSCLC

Patients with non-small-cell lung cancer who express high levels of transcriptional coactivator with PDZ-binding motif may be a clinically distinct subgroup with an unfavourable prognosis, researchers report.

16 Jul 2014

CIP2A pathway involved in erlotinib response

Researchers have identified a novel mechanism, involving the cancerous inhibitor of protein phosphatase 2A pathway, which mediates the anti-tumour effects of erlotinib in non-small-cell lung cancer cells without epidermal growth factor receptor mutations.

16 Jul 2014

Use ADHD questionnaire ‘with caution’ in bipolar patients

A questionnaire used to determine whether or not someone has attention-deficit hyperactivity disorder should be used with caution in patients with bipolar disorder, Swiss researchers suggest.

16 Jul 2014

Thirteen scientists receive grant to identify new treatments, cure for psoriasis

Thirteen scientists received a total of $1.05 million in funding from the National Psoriasis Foundation for projects that aim to identify new treatments and a cure for psoriasis—an autoimmune disease that appears on the skin, affecting 7.5 million Americans—and psoriatic arthritis—an inflammatory arthritis that affects the joints and tendons, occurring in up to 30 percent of people with psoriasis.

16 Jul 2014

Impact of kidney donation on ability to change life insurance is unknown

People who selflessly step up and donate a kidney can face insurance challenges afterwards, despite the lack of evidence that they have increased health risks.

16 Jul 2014

Research sheds light on key mechanism prevalent in Alzheimer's disease patients

Alzheimer's disease affects approximately 5.2 million people in the United States alone, and it is the nation's sixth leading cause of death.

16 Jul 2014

Anti-clotting treatment not needed for all kids who undergo spine operations

Blood clots occur so rarely in children undergoing spine operations that most patients require nothing more than vigilant monitoring after surgery and should be spared risky and costly anti-clotting medications, according to a new Johns Hopkins Children's Center study.

16 Jul 2014

Lilly, Immunocore enter into co-discovery and co-development collaboration to develop cancer therapies

Eli Lilly and Company and Immunocore Limited today announced they have entered into a co-discovery and co-development collaboration to research and potentially develop novel T cell-based cancer therapies.

16 Jul 2014

Isis earns $1 million payment from GSK related to advancement of ISIS-TTRRx

Isis Pharmaceuticals, Inc. announced today that it has earned a $1 million milestone payment from GlaxoSmithKline (GSK) related to the advancement of the Phase 2/3 study of ISIS-TTRRx in patients with familial amyloid polyneuropathy (FAP).

16 Jul 2014

Medical Research News

Deadly neurodegenerative disease treated in worms gives hope for humans

Phase III research shows that new drug improves symptoms related to plaque psoriasis

Investigators identify gene that underlies devastating autoinflammatory condition in children

Scientists reveal secrets of cell membrane proteins

People with mild traumatic brain injury may have brain damage and memory problems

Robot-assisted surgery to control prostate cancer effective in controlling disease for 10 years

Scientist fights extremely aggressive and difficult-to-treat form of breast cancer

Potassium supplements with loop diuretics increase survival rates of heart failure patients

Single injection of protein FGF1 enough to restore blood sugar levels

Scientists may be able to entomb malaria parasite in prison

Symptom remission main predictor of functional outcomes in psychosis

TAZ represents a novel therapeutic target in NSCLC

CIP2A pathway involved in erlotinib response

Use ADHD questionnaire ‘with caution’ in bipolar patients

Thirteen scientists receive grant to identify new treatments, cure for psoriasis

Impact of kidney donation on ability to change life insurance is unknown

Research sheds light on key mechanism prevalent in Alzheimer's disease patients

Anti-clotting treatment not needed for all kids who undergo spine operations

Lilly, Immunocore enter into co-discovery and co-development collaboration to develop cancer therapies

Isis earns $1 million payment from GSK related to advancement of ISIS-TTRRx

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News